aloxistatin has been researched along with Autoimmune Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, A; Boehm, BO; Brücken, R; Burster, T; Kalbacher, H; Palesch, D; Schäfer, N; Sienczyk, M; Sun, Z; Zou, F | 1 |
1 other study(ies) available for aloxistatin and Autoimmune Diabetes
| Article | Year |
|---|---|
Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patients.
Topics: Blotting, Western; Carrier Proteins; Cathepsin G; Cell-Penetrating Peptides; Cells, Cultured; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Humans; Leucine; Pepstatins; Polymerase Chain Reaction; Proinsulin; T-Lymphocytes | 2011 |